HMRC closes loophole that allowed tax relief on funding medical researchBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f387 (Published 21 January 2013) Cite this as: BMJ 2013;346:f387
- Nigel Hawkes
A scheme designed to exploit tax breaks on medical research has been ruled unlawful in court after a challenge by HM Revenue and Customs (HMRC).
Matrix Securities promoted a scheme in which wealthy investors were offered tax relief far in excess of their investment, by exploiting a tax break meant to encourage investment in medical research. A total of 83 investors put up £28m (€33m; $45m) and borrowed another £86m from banks, allegedly to invest in research …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial